View Older Stories View More Recent Stories

Sep 5, 2023 03:01AM Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
Aug 29, 2023 03:01AM Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
Aug 22, 2023 03:01AM Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
Aug 15, 2023 04:32AM Mainz Biomed (MYNZ) Reports H1 Results, Provides Corporate Update
Aug 15, 2023 03:01AM Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
Aug 1, 2023 05:18AM Mainz Biomed (MYNZ) Announces Live Launch of ColoAlert with Marylebone Laboratory in the UK
Aug 1, 2023 03:01AM Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
Jul 18, 2023 04:39AM Mainz Biomed (MYNZ) Announces Collaboration with Fugene Genetics in Israel
Jul 18, 2023 03:01AM Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
Jun 29, 2023 05:44AM Mainz Biomed (MYNZ) Announces $50M in New Funding
Jun 29, 2023 03:01AM Mainz Biomed Secures up to $50M in New Funding
Jun 28, 2023 03:01AM Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
Jun 20, 2023 06:11AM Mainz Biomed (MYNZ) Partners with Bioclinica in Romania
Jun 20, 2023 03:01AM Mainz Biomed Expands into Romania Through Partnership with Bioclinica
May 31, 2023 03:01AM Mainz Biomed Expands Commercial Footprint into Poland
May 24, 2023 03:01AM Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper
May 16, 2023 04:35AM Mainz Biomed (MYNZ) Reports Q1 Revenue of $250K, EPS of ($0.45)
May 16, 2023 03:01AM Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 10, 2023 03:01AM Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
May 3, 2023 03:01AM Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners
May 1, 2023 03:01AM Mainz Biomed to Participate in Digestive Disease Week 2023
May 1, 2023 03:01AM Mainz Biomed to Participate in Digestive Disease Week 2023
Apr 27, 2023 03:01AM Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
Apr 27, 2023 03:01AM Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
Apr 26, 2023 05:34AM Mainz Biomed (MYNZ) Partners with the Instituto de Microecologia to Expand ColoAlert Commercialization in Spain and Portugal
Apr 26, 2023 03:01AM Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
Apr 26, 2023 03:01AM Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
Apr 10, 2023 05:54AM Mainz Biomed (MYNZ) Reports FY22 Results
Apr 10, 2023 03:01AM Mainz Biomed Provides Full Year 2022 Financial Results
Apr 10, 2023 03:01AM Mainz Biomed Provides Full Year 2022 Financial Results
Apr 4, 2023 05:56AM Mainz Biomed (MYNZ) Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
Apr 4, 2023 03:01AM Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
Apr 4, 2023 03:01AM Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
Mar 29, 2023 05:28AM Mainz Biomed (MYNZ) Reports Positive Results from Feasibility Study Evaluating its Portfolio of mRNA Biomarkers
Mar 29, 2023 03:01AM Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
Mar 29, 2023 03:01AM Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
Mar 21, 2023 03:01AM Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
Mar 21, 2023 03:01AM Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
Mar 15, 2023 03:01AM Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Mar 15, 2023 03:01AM Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Mar 8, 2023 03:01AM Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
Mar 8, 2023 03:01AM Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
Feb 28, 2023 08:01AM Mainz Biomed to Appear on ClearThink IR’s Virtual Live Event on Wednesday, March 1, 2023 at 12 Noon ET
Feb 21, 2023 05:53AM Mainz Biomed (MYNZ) Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
Feb 21, 2023 03:01AM Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
Feb 21, 2023 03:01AM Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
Feb 15, 2023 06:00AM Mainz Biomed (MYNZ) Expands Into Spain and UK
Feb 15, 2023 03:01AM Mainz Biomed Expands European Commercial Footprint and Enters Markets in Spain and UK
Feb 15, 2023 03:01AM Mainz Biomed Expands European Commercial Footprint and Enters Markets in Spain and UK
Jan 18, 2023 05:33AM Mainz Biomed (MYNZ) Launches Corporate Health Program in Germany for ColoAlert
View More Recent Stories View Older Stories